Endogena Therapeutics

Endogena

This clinical-stage biotechnology company develops small-molecule regenerative medicines to treat degenerative eye diseases and other conditions for patients with high unmet medical needs.

Endogenous

This company develops small-molecule drugs that activate a patient's own stem cells to repair tissues for treating degenerative diseases.

Surrozen

This biotechnology company develops Wnt-based antibody therapeutics to repair and restore tissue function for patients with sight-threatening ophthalmic conditions.

EyeBio

This biotechnology company develops ocular therapies to treat retinal diseases such as diabetic macular edema and age-related macular degeneration for patients with vision loss.

Rejuveron Life Sciences AG

This biotechnology company develops regenerative therapies and medicines for patients with age-related diseases and vision loss.

Beacon Therapeutics

This company develops ophthalmic gene therapies to restore vision for patients with rare and prevalent retinal diseases causing blindness.

Endurance Bio

This biotechnology company develops oral small molecule therapeutics for patients with neurodegenerative and metabolic diseases to restore mitochondrial and lysosomal health.

Vedere Bio

This biotechnology company develops ocular gene therapies to restore functional vision for patients with inherited retinal degenerations and geographic atrophy.